the main FDA-affirmed adjuvant treatment alternative in this setting was interferon (IFN)- α, a medication with variable viability and treatment-constraining toxicities.2 The approach of checkpoint inhibitors and focused on operators have given oncologists more to work with.

Adjuvant Therapies - Plexus